Prostate drug may slow Parkinson's disease
Recent research shows that a prostate medication may help to slow the progression of Parkinson’s disease. Existing Parkinson’s treatments can help with some of the symptoms but are unable to slow or reverse the loss of neurons.
Scientists feel that the medication Terazosin may help by activating an enzyme called PGK1 to prevent brain cell death.
Researchers from the University of Iowa and the Beijing Institute for Brain Disorders examined over 17,000 participants. Patients on the drugs targeting PGK1 appeared to fare better in terms of Parkinson’s disease symptoms and progression.
Researchers are hopeful for further clinical trials testing the use of this medication in patients with Parkinson’s disease. The findings have been published in the Journal of Clinical Investigation.
A medicine for enlarged prostates may benefit brain cells damaged by Parkinson’s, scientists find.
Read full article ↗